Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian markets continue to trade firm
Thu, 14 Aug 11:30 am

Indian equity markets opened the well above the dotted line and have continued to trade firm during the morning trading session. All the sectoral indices are witnessing buying interest with stocks from capital goods and consumer durables being the leading gainers in the pack.

The BSE-Sensex is trading up 138 points. The NSE-Nifty is trading up 35 points. The BSE Mid Cap index is trading up 0.6% and the BSE Small Cap index is trading up 0.4%. The rupee is trading at 61.24 to the US dollar.

Software stocks are trading mixed today. While Tech Mahindra is leading the gainers; HCL Technologies is leading the losers. Mindtree has announced that it has been selected by the British Broadcasting Corporation (BBC) to test a range of its digital products in a two year deal. Digital products include applications and websites that can be accessed by PCs, mobile devices, cloud, digital TV, IPTV, terrestrial, cable or satellite TV and the internet. Mindtree was one among seven IT firms bidding for the contract. The estimated size of the contract is between 15 m and 25 m Pounds. Mindtree is trading flat today.

Indian pharma stock markets are trading mixed, with Natco pharma and Ranbaxy Ltd being the leading gainers while Elder pharma and Indoco being the leading losers in the pack. Sun pharmaceuticals has declared June quarter 2015 results (1QFY15). Net sales grew by 13% YoY during the quarter. The Indian formulations business grew by 17% YoY while the US business grew by 7% (in dollar terms) YoY. International formulations outside US grew by just 2% YoY for the said period. The EBITDA margins were same as of the last year at 44% during the quarter. On the bottom line, the company reported net profit of Rs 13.9 bn vs loss of 25.1 bn during 1QFY14. This loss was due to provision made for one off liability towards protonix.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Indian markets continue to trade firm". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms